Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 10
2021 37
2022 27
2023 32
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Results by year

Filters applied: . Clear all
Page 1
Introducing Immunotherapy Advances.
Elliott T. Elliott T. Immunother Adv. 2020 Nov 25;1(1):ltaa009. doi: 10.1093/immadv/ltaa009. eCollection 2021 Jan. Immunother Adv. 2020. PMID: 36284897 Free PMC article. No abstract available.
Immunotherapy advances: One year on.
Elliott T. Elliott T. Immunother Adv. 2022 Jan 11;2(1):ltac001. doi: 10.1093/immadv/ltac001. eCollection 2022. Immunother Adv. 2022. PMID: 35919492 Free PMC article. No abstract available.
Correction.
[No authors listed] [No authors listed] Immunother Adv. 2022 Aug 11;2(1):ltac018. doi: 10.1093/immadv/ltac018. eCollection 2022. Immunother Adv. 2022. PMID: 35967910 Free PMC article.
Immunology of allergen immunotherapy.
Rahman RS, Wesemann DR. Rahman RS, et al. Immunother Adv. 2022 Nov 25;2(1):ltac022. doi: 10.1093/immadv/ltac022. eCollection 2022. Immunother Adv. 2022. PMID: 36530352 Free PMC article. Review.
A historical perspective on HLA.
Bodmer W. Bodmer W. Immunother Adv. 2023 Aug 17;3(1):ltad014. doi: 10.1093/immadv/ltad014. eCollection 2023. Immunother Adv. 2023. PMID: 37636243 Free PMC article. Review.
Prevention vs treatment of rheumatoid arthritis.
Klareskog L, Alfredsson L. Klareskog L, et al. Immunother Adv. 2023 Aug 29;3(1):ltad016. doi: 10.1093/immadv/ltad016. eCollection 2023. Immunother Adv. 2023. PMID: 37662832 Free PMC article. Review.
TIGIT-based immunotherapeutics in lung cancer.
Patel AJ, Middleton GW. Patel AJ, et al. Immunother Adv. 2023 May 26;3(1):ltad009. doi: 10.1093/immadv/ltad009. eCollection 2023. Immunother Adv. 2023. PMID: 37325585 Free PMC article. Review.
DC-targeting lentivectors for cancer immunotherapy.
Gea-Mallorquí E, Rowland-Jones S. Gea-Mallorquí E, et al. Immunother Adv. 2023 Nov 1;3(1):ltad023. doi: 10.1093/immadv/ltad023. eCollection 2023. Immunother Adv. 2023. PMID: 38020311 Free PMC article. Review.
Cancer vaccines: from an immunology perspective.
Makker S, Galley C, Bennett CL. Makker S, et al. Immunother Adv. 2023 Dec 21;4(1):ltad030. doi: 10.1093/immadv/ltad030. eCollection 2024. Immunother Adv. 2023. PMID: 38223410 Free PMC article. Review.
92 results